Footage of a plane flipping over after landing in poor weather in Toronto, Canada, has also been widely shared online, further fuelling alarm.
notes a 48% drop in violent incidents in Maoist-related violence - from 1,136 in 2013 to 594 in 2023 - and a 65% decline in related deaths, from 397 to 138.However, it acknowledges a slight rise in security force casualties in 2023 compared to 2022, attributed to intensified operations in core Maoist areas.
The report says Chhattisgarh remained the worst-affected state in 2023, accounting for 63% of all Left-Wing Extremism (LWE) incidents and 66% of the related deaths.Jharkhand followed, with 27% of the violence and 23% of the deaths. The remaining incidents were reported from Maharashtra, Odisha, Madhya Pradesh and Bihar.The collapse of Maoism in Chhattisgarh, a stronghold of the insurgency, offers key clues to the movement's broader decline.
A decade ago, the state's police were seen as weak, according to Mr Ganapathy."Today, precise state-led strikes, backed by central paramilitary forces, have changed the game. While paramilitary held the ground, state forces gathered intelligence and launched targeted operations. It was clear role delineation and coordination," he said.
Mr Ganapathy adds that access to mobile phones, social media, roads and connectivity have made people more aware and less inclined to support an armed underground movement.
"People have become aspirational, mobile phones and social media have become widespread and people are exposed to the outside world. Maoists also cannot operate in hiding in remote jungles while being out of sync with new social realities.Prof Rob Jones said: "Patients who received the hormone therapy with a placebo had an overall survival of around 20 months and those who received the capivasertib with the hormone therapy had an extra 39 months.
"It really is a doubling of survival time so that really is significant. It's not just a statistic - it's a real life impact for people to spend extra time with their relatives, with their friends."Dr Nicola Williams, national director of support and delivery at Health and Care Research Wales, said: "A breast cancer diagnosis can be devastating and one in seven women will be diagnosed with the disease in their lifetime.
"This diagnosis is even more painful if you're told your cancer is incurable."Thanks to the trial and the licensing of capivasertib, when used alongside a standard hormonal therapy, patients like Gwen now have the potential to receive a very significant extension in their lifespan and improved quality of life."